Stay updated on Hepatic Impairment Impact on Risdiplam: Clinical Trial

Sign up to get notified when there's something new on the Hepatic Impairment Impact on Risdiplam: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Hepatic Impairment Impact on Risdiplam: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Adds a dedicated Locations section listing Florida and Texas sites, replacing the previous location blocks; removes the HHS Vulnerability Disclosure link and updates the page revision to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-24T14:08:11.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2, replacing Revision: v3.3.1, indicating a system/UI update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:54:06.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.3.1 and no longer shows Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:28:52.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The government funding notice banner at the top of the study record was removed. The page still shows the study details, eligibility criteria, and locations.
    Difference
    0.4%
    Check dated 2025-11-17T06:45:25.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    No substantive changes are visible between the two screenshots; the study details and page sections remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:17:11.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Core updates include a status/operational notice about funding and a new resource entry (Spinal muscular atrophy), plus a version bump to v3.2.0. The funding notice is the most impactful change for users.
    Difference
    3%
    Check dated 2025-10-05T10:26:01.000Z thumbnail image

Stay in the know with updates to Hepatic Impairment Impact on Risdiplam: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Hepatic Impairment Impact on Risdiplam: Clinical Trial page.